Assignee
ARCHEMIX CORP
US12 patents
Top patents by PatentIndex Score
US7767803B2Aug 3, 2010
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
ARCHEMIX CORP63 citations95
US7125660B2Oct 24, 2006
Nucleic acid sensor molecules and methods of using same
ARCHEMIX CORP77 citations93
US7579456B2Aug 25, 2009
Aptamer therapeutics useful in the treatment of complement-related disorders
ARCHEMIX CORP24 citations92
US7803931B2Sep 28, 2010
Aptamer therapeutics useful in the treatment of complement-related disorders
ARCHEMIX CORP19 citations90
US7566701B2Jul 28, 2009
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
ARCHEMIX CORP30 citations90
US7538211B2May 26, 2009
Aptamer therapeutics useful in the treatment of complement-related disorders
ARCHEMIX CORP33 citations90
US7998939B2Aug 16, 2011
Aptamers that bind thrombin with high affinity
ARCHEMIX CORP16 citations79
US7998940B2Aug 16, 2011
Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics
ARCHEMIX CORP6 citations71
US7960102B2Jun 14, 2011
Regulated aptamer therapeutics
ARCHEMIX CORP6 citations62
US8039443B2Oct 18, 2011
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
ARCHEMIX CORP5 citations61
US7589073B2Sep 15, 2009
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
ARCHEMIX CORP4 citations60
US7579450B2Aug 25, 2009
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
ARCHEMIX CORP4 citations57